Skip to main content

ADVERTISEMENT

Non-Small-Cell Lung Cancer

Videos
10/24/2018
At the 23rd Annual Perspectives in Thoracic Oncology meeting, Dr Mulshine discussed the importance of lung cancer screening.
At the 23rd Annual Perspectives in Thoracic Oncology meeting, Dr Mulshine discussed the importance of lung cancer screening.
At the 23rd Annual Perspectives...
10/24/2018
Oncology
10/13/2018
Osimertinib remains the standard approach for first line therapy in EGFR mutated NSCLC.
Osimertinib remains the standard approach for first line therapy in EGFR mutated NSCLC.
Osimertinib remains the standard...
10/13/2018
Oncology
10/13/2018
For patients with NSCLC and ALK mutation, first-line therapy with alectinib is standard care, however, sequence of therapy is not so readily defined.
For patients with NSCLC and ALK mutation, first-line therapy with alectinib is standard care, however, sequence of therapy is not so readily defined.
For patients with NSCLC and ALK...
10/13/2018
Oncology
10/12/2018
Adding a liquid biopsy to standard care tumor surveillance led to a marked increase in the detection of mutations that can be targeted with therapy, a recent study has shown.
Adding a liquid biopsy to standard care tumor surveillance led to a marked increase in the detection of mutations that can be targeted with therapy, a recent study has shown.
Adding a liquid biopsy to...
10/12/2018
Oncology